PPC Stock Analysis: Pilgrims Pride | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.493m USD | 12M Return: -27.3% | US72147K1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 41.7M
EPS Trend: 67.2%
Qual. Beats: 0
Rev. Trend: 94.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pilgrims Pride Corporation (NASDAQ: PPC) is a vertically integrated producer and processor of fresh, frozen, and value-added chicken and pork products, serving retail, foodservice, and export markets across the United States, Europe, and Mexico. Its product portfolio spans fresh whole and cut-up chicken, marinated and non-marinated parts, primary pork cuts, fully cooked and ready-to-cook prepared items, as well as growing categories such as plant-based proteins, ready-to-eat meals, multi-protein frozen foods, and desserts. The company markets its products under a wide range of owned and licensed brands, including Pilgrims, Just BARE, Moy Park, Gold Kist, Pierce Chicken, To-Ricos, and Del Dia, among others. Founded in 1946 and headquartered in Greeley, Colorado, Pilgrims Pride operates as a subsidiary of JBS N.V., the global meat and food processing company.
The company operates in the highly consolidated packaged poultry and meats segment of the consumer staples sector, where scale, vertical integration, and supply-chain efficiency are key competitive advantages. Its diversified geographic footprint across North American and European markets helps offset regional demand and commodity cycle volatility, though profitability remains closely tied to feed input costs, labor availability, and processing capacity utilization.
- Chicken breast prices and feed costs drive quarterly margins
- JBS parent company capital allocation influences dividend and buyback policy
- Mexico and Europe prepared foods segment revenue growth offsets US poultry volatility
| Net Income: 545.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -7.84 > 1.0 |
| NWC/Revenue: 5.29% < 20% (prev 9.01%; Δ -3.72% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.22b > Net Income 545.6m |
| Net Debt (2.90b) to EBITDA (1.44b): 2.02 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.8m) vs 12m ago 0.24% < -2% |
| Gross Margin: 9.62% > 18% (prev 13.79%; Δ -4.18% > 0.5%) |
| Asset Turnover: 183.0% > 50% (prev 179.6%; Δ 3.36% > 0%) |
| Interest Coverage Ratio: 5.81 > 6 (EBIT TTM 957.6m / Interest Expense TTM 164.9m) |
| A: 0.10 (Total Current Assets 3.72b - Total Current Liabilities 2.74b) / Total Assets 10.0b |
| B: 0.24 (Retained Earnings 2.36b / Total Assets 10.0b) |
| C: 0.10 (EBIT TTM 957.6m / Avg Total Assets 10.1b) |
| D: 0.60 (Book Value of Equity 3.75b / Total Liabilities 6.27b) |
| Altman-Z'' = 2.67 = A |
| DSRI: 0.76 (Receivables 926.1m/1.21b, Revenue 18.4b/18.2b) |
| GMI: 1.43 (GM 13.79% / 9.62%) |
| AQI: 1.00 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.01 (Revenue 18.4b / 18.2b) |
| TATA: -0.07 (NI 545.6m - CFO 1.22b) / TA 10.0b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of October 07, 2026, the stock is trading at USD 27.99 with a total of 1,964,615 shares traded. Over the past week, the price has changed by -0.43%, over one month by -6.67%, over three months by -2.30% and over the past year by -27.34%.
Current recommended Stop Loss: 26.10 (which is 6.8% or 1.6 ATR below the current price).
Pilgrims Pride has received a consensus analysts rating of 3.11. Therefore, it is recommended to hold PPC.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 33.3 | 18.9% |
P/E Trailing = 12.2838
P/E Forward = 9.5057
P/S = 0.3522
P/B = 1.8402
P/EG = 0.4882
Revenue TTM = 18.4b USD
EBIT TTM = 957.6m USD
EBITDA TTM = 1.44b USD
Long Term Debt = 2.86b USD (from longTermDebt, last quarter)
Short Term Debt = 913k USD (from shortTermDebt, last quarter)
Debt = 3.30b USD (from shortLongTermDebtTotal, last quarter) + Leases 250.7m
Net Debt = 2.90b USD (calculated: Debt 3.30b - CCE 398.3m)
Enterprise Value = 9.40b USD (6.49b + Debt 3.30b - CCE 398.3m)
Interest Coverage Ratio = 5.81 (Ebit TTM 957.6m / Interest Expense TTM 164.9m)
EV/FCF = 30.87x (Enterprise Value 9.40b / FCF TTM 304.4m)
FCF Yield = 3.24% (FCF TTM 304.4m / Enterprise Value 9.40b)
FCF Margin = 1.65% (FCF TTM 304.4m / Revenue TTM 18.4b)
Net Margin = 2.96% (Net Income TTM 545.6m / Revenue TTM 18.4b)
Gross Margin = 9.62% ((Revenue TTM 18.4b - Cost of Revenue TTM 16.7b) / Revenue TTM)
Gross Margin QoQ = 7.34% (prev 7.62%)
Tobins Q-Ratio = 0.94 (Enterprise Value 9.40b / Total Assets 10.0b)
Interest Expense / Debt = 4.99% (Interest Expense 164.9m / Debt 3.30b)
Taxrate = 30.90% (244.1m / 789.7m)
NOPAT = 661.7m (EBIT 957.6m * (1 - 30.90%))
Current Ratio = 1.36 (Total Current Assets 3.72b / Total Current Liabilities 2.74b)
Debt / Equity = 0.88 (Debt 3.30b / totalStockholderEquity, last quarter 3.75b)
Debt / EBITDA = 2.02 (Net Debt 2.90b / EBITDA 1.44b)
Debt / FCF = 9.54 (Net Debt 2.90b / FCF TTM 304.4m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.42% (Net Income 545.6m / Total Assets 10.0b)
RoE = 14.85% (Net Income TTM 545.6m / Total Stockholder Equity 3.67b)
RoCE = 14.65% (EBIT 957.6m / Capital Employed (Equity 3.67b + L.T.Debt 2.86b))
RoIC = 9.61% (NOPAT 661.7m / Invested Capital 6.89b)
WACC = 3.88% (E(6.49b)/V(9.80b) * Re(4.10%) + D(3.30b)/V(9.80b) * Rd(4.99%) * (1-Tc(0.31)))
Discount Rate = 4.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.59 | Cagr: 0.25%
[DCF] Terminal Value 73.10% ; FCFF base≈622.8m ; Y1≈546.2m ; Y5≈441.3m
[DCF] Fair Price = 17.55 (EV 7.08b - Net Debt 2.90b = Equity 4.18b / Shares 238.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 67.18 | EPS CAGR: 65.77% | SUE: -0.60 | # QB: 0
Revenue Correlation: 94.71 | Revenue CAGR: 2.93% | SUE: -0.56 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.69 | Chg30d=-3.83% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=2.39 | Chg30d=-3.75% | Revisions=-62% | GrowthEPS=-53.7% | GrowthRev=+0.2%
EPS next Year (2027-12-31): EPS=2.76 | Chg30d=-8.89% | Revisions=-62% | GrowthEPS=+15.5% | GrowthRev=+2.3%
[Analyst] Revisions Ratio: -81% (up=0, down=13)